当前位置：首页 / TBT/SPS通报 /CDC 16 (4982) P3 Labelling and marking of pharmaceutical products - Specification (5 pages, in English)

CDC 16 (4982) P3 Labelling and marking of pharmaceutical products - Specification (5 pages, in English)

来源：epingalert 发布时间：2017-02-20 浏览量：*
通告成员：
Tanzania
通告类型：
TBT
通告发布时间：
2017-02-20
评议截止时间：
2017-04-21
通告描述：
<span style="font-size:x-small;font-face:Verdana;"><span lang="EN-GB" style="font-family:'Verdana','sans-serif';font-size:9pt;">Th<span style="letter-spacing:-0.05pt;">i</span>s<span style="letter-spacing:0.2pt;"> </span>S<span style="letter-spacing:0.1pt;">t</span>a<span style="letter-spacing:-0.05pt;">n</span><span style="letter-spacing:0.1pt;">d</span>ard<span style="letter-spacing:0.15pt;"> </span><span style="letter-spacing:0.05pt;">s</span><span style="letter-spacing:0.1pt;">p</span>e<span style="letter-spacing:0.05pt;">c</span><span style="letter-spacing:-0.05pt;">i</span><span style="letter-spacing:0.1pt;">f</span><span style="letter-spacing:-0.05pt;">i</span>es<span style="letter-spacing:0.2pt;"> </span>g<span style="letter-spacing:-0.05pt;">e</span><span style="letter-spacing:0.1pt;">n</span>eral<span style="letter-spacing:0.3pt;"> </span>m<span style="letter-spacing:0.1pt;">a</span>n<span style="letter-spacing:-0.05pt;">d</span>a<span style="letter-spacing:0.1pt;">t</span>o<span style="letter-spacing:0.15pt;">r</span>y a<span style="letter-spacing:-0.05pt;">n</span>d<span style="letter-spacing:0.35pt;"> </span><span style="letter-spacing:0.1pt;">o</span>p<span style="letter-spacing:0.1pt;">t</span><span style="letter-spacing:-0.05pt;">i</span>o<span style="letter-spacing:0.05pt;">n</span>al<span style="letter-spacing:0.15pt;"> </span><span style="letter-spacing:0.05pt;">r</span><span style="letter-spacing:0.1pt;">e</span>q<span style="letter-spacing:-0.05pt;">ui</span><span style="letter-spacing:0.15pt;">r</span>e<span style="letter-spacing:-0.05pt;">m</span><span style="letter-spacing:0.1pt;">e</span>n<span style="letter-spacing:0.1pt;">t</span>s of<span style="letter-spacing:0.55pt;"> </span>a<span style="letter-spacing:0.5pt;"> </span><span style="letter-spacing:-0.05pt;">l</span>a<span style="letter-spacing:0.05pt;">b</span>e<span style="letter-spacing:-0.05pt;">l for pharmaceutical products</span>.<span style="letter-spacing:0.4pt;"> </span>It a<span style="letter-spacing:-0.05pt;">l</span><span style="letter-spacing:0.05pt;">s</span>o<span style="letter-spacing:2.6pt;"> </span><span style="letter-spacing:0.1pt;">g</span><span style="letter-spacing:-0.05pt;">i</span><span style="letter-spacing:0.05pt;">v</span>es requirements for secondary packaging or where there is no secondary packaging, primary packaging, small containers, blisters and strips.</span></span>
文档编号：
G/TBT/N/TZA/67
查看文档：
原文文档   翻译文档
ICS Code：

11.120.01 - Pharmaceutics in general
通告目的：

Consumer information, labelling (TBT)
相关产品：
Pharmaceutical (ICS: 11.120.01)

热门文章

lINKS
相关链接